Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Palatin Technologies (PTN)

0.393   0.002 (0.49%) 01-21 17:32
Open: 0.39 Pre. Close: 0.3911
High: 0.4299 Low: 0.39
Volume: 2,204,214 Market Cap: 91M
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL3994, a natriuretic peptide receptor (NPR)-A agonist and synthetic mimetic of the endogenous neuropeptide hormone atrial natriuretic peptide for cardiovascular indications; and PL5028, an NPR-A and NPR-binder to treat cardiovascular and fibrotic diseases, including reducing cardiac hypertrophy and fibrosis. The company was incorporated in 1986 and is based in Cranbury, New Jersey.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.43 - 0.433 0.433 - 0.436
Low: 0.385 - 0.388 0.388 - 0.39
Close: 0.386 - 0.391 0.391 - 0.394

Technical analysis

as of: 2022-01-21 4:29:38 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 0.59     One year: 0.67
Support: Support1: 0.39    Support2: 0.32
Resistance: Resistance1: 0.50    Resistance2: 0.57
Pivot: 0.45
Moving Average: MA(5): 0.40     MA(20): 0.47
MA(100): 0.47     MA(250): 0.57
MACD: MACD(12,26): -0.03     Signal(9): -0.02
Stochastic oscillator: %K(14,3): 4.55     %D(3): 4.78
RSI: RSI(14): 32.47
52-week: High: 1.30  Low: 0.33  Change(%): -55.3
Average Vol(K): 3-Month: 11481  10-Days: 1552

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
PTN has closed above bottom band by 17.1%. Bollinger Bands are 32.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 21 Jan 2022
Palatin: Pre-clinical Data Show Positive Effects Of Melanocortins For Ulcerative Colitis - Nasdaq

Sun, 02 Jan 2022
Which Penny Stocks Are Investors Watching in 2022? 3 To Check Out - Kilgore News Herald

Tue, 28 Dec 2021
Palatin Announces Initiation of Pivotal Phase 3 PL9643 MELODY-1 Clinical Trial in Patients with Dry Eye Disease - PRNewswire

Thu, 23 Dec 2021
Is Palatin Technologies, Inc. (PTN) Stock at the Top of the Biotechnology Industry? - InvestorsObserver

Mon, 06 Dec 2021
Here's Why Palatin Technologies, Inc. (PTN) Is a Great 'Buy the Bottom' Stock Now - Nasdaq

Mon, 29 Nov 2021
Biofrontera, Palatin surge amid social media chatter - Seeking Alpha

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  AMEX
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 229
Shares Float (M) 226
% Held by Insiders 3.33
% Held by Institutions 22.79
Shares Short (K) 10,060
Shares Short P. Month (K) 10,500

Stock Financials

EPS -0.100
EPS Est This Year -0.350
EPS Est Next Year -0.060
Book Value (p.s.) 0.350
Profit Margin
Operating Margin -20007.61
Return on Assets (ttm) -15.6
Return on Equity (ttm) -24.8
Qtrly Rev. Growth -100.0
Gross Profit (p.s.) -0.060
Sales Per Share 0.001
EBITDA (p.s.) -0.103
Qtrly Earnings Growth
Operating Cash Flow (M) 41
Levered Free Cash Flow (M) 48

Stock Valuations

PE Ratio -3.93
PEG Ratio
Price to Book value 1.12
Price to Sales 763.62
Price to Cash Flow

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.